Deal Flow Forecast 2024
Following a subdued eighteen months leaving global private equity sitting on an estimated £2.59 trillion of “dry powder” with increasing pressure to deploy in 2024, Compass Executives welcomed a cohort of health and social care advisors for the latest round table discussion addressing whether a more positive trading environment will translate into more transactions in the sector.
Topics included current trading levels, quality of assets coming to market, trends for active sub-sectors, stability of the debt markets, and the impact a possible change of government could have on M&A activity.
Contributors
- Andrew Nicholson – Managing Director, European Head of Healthcare Investment Banking, Baird
- Sharon Lamb – Partner of Health & Life Sciences, McDermott, Will & Emery LLP
- Vivienne Howell – Head of Healthcare, Civitas
- Matthew Lee – Managing Director & Co-Head of Healthcare, Europe, Lincoln International
- Gordon Hamilton – Managing Director, Alpha Helix Corporate Finance
- Craig Grant – former CFO/Strategy Officer, Family First Nurseries Group
- Dasos Kirtsides – Head of Healthcare, Shawbrook
- Dominic Dali – Managing Partner, Sovereign Capital
- Sam Leighton-Smith – Group MD, Compass Recruitment Solutions
- Luke Osborne – Director, Compass Executives
- Paul Spicer – Senior Associate, Compass Executives
Key areas of discussion
Cautious optimism for a better year ahead, potential changes within the political landscape and the impact that this might have on pricing, the demand for AI and technology companies, appetite from investors.
To obtain your copy of the full report and the responses to key area of discussion, download here: Deal Flow Forecast 2024
For further information about Compass Executives news and events, click here.